opsd_human
NAME
5DGY
ORGANISM
Human (Homo sapiens)
PROTEIN NAME
opsd_human
SOURCE
SWISSPROT
SEQUENCE
Perspective:
Wild-type
Construct
|
|||||||||
N-term | |||||||||
M
|
N
|
G
|
T
|
E
|
G
|
P
|
N
|
F
|
Y
|
10 |
V
|
P
|
F
|
S
|
N
|
A
|
T
|
G
|
V
|
V
|
20 |
R
|
S
|
P
|
F
|
E
|
Y
|
P
|
Q
|
Y
|
Y
|
30 |
TM1 | |||||||||
L
|
A
|
E
|
P
|
W
|
Q
|
F
|
S
|
M
|
L
|
40 |
A
|
A
|
Y
|
M
|
F
|
L
|
L
|
I
|
V
|
L
|
50 |
G
|
F
|
P
|
I
|
N
|
F
|
L
|
T
|
L
|
Y
|
60 |
ICL1 | |||||||||
V
|
T
|
V
|
Q
|
H
|
K
|
K
|
L
|
R
|
T
|
70 |
TM2 | |||||||||
P
|
L
|
N
|
Y
|
I
|
L
|
L
|
N
|
L
|
A
|
80 |
V
|
A
|
D
|
L
|
F
|
M
|
V
|
L
|
G
|
G
|
90 |
F
|
T
|
S
|
T
|
L
|
Y
|
T
|
S
|
L
|
H
|
100 |
ECL1 | TM3 | ||||||||
G
|
Y
|
F
|
V
|
F
|
G
|
P
|
T
|
G
|
C
|
110 |
|
|||||||||
N
|
L
|
E
|
G
|
F
|
F
|
A
|
T
|
L
|
G
|
120 |
G
|
E
|
I
|
A
|
L
|
W
|
S
|
L
|
V
|
V
|
130 |
L
|
A
|
I
|
E
|
R
|
Y
|
V
|
V
|
V
|
C
|
140 |
ICL2 | |||||||||
K
|
P
|
M
|
S
|
N
|
F
|
R
|
F
|
G
|
E
|
150 |
TM4 | |||||||||
N
|
H
|
A
|
I
|
M
|
G
|
V
|
A
|
F
|
T
|
160 |
W
|
V
|
M
|
A
|
L
|
A
|
C
|
A
|
A
|
P
|
170 |
ECL2 | |||||||||
P
|
L
|
A
|
G
|
W
|
S
|
R
|
Y
|
I
|
P
|
180 |
E
|
G
|
L
|
Q
|
C
|
S
|
C
|
G
|
I
|
D
|
190 |
Y
|
Y
|
T
|
L
|
K
|
P
|
E
|
V
|
N
|
N
|
200 |
TM5 | |||||||||
E
|
S
|
F
|
V
|
I
|
Y
|
M
|
F
|
V
|
V
|
210 |
H
|
F
|
T
|
I
|
P
|
M
|
I
|
I
|
I
|
F
|
220 |
F
|
C
|
Y
|
G
|
Q
|
L
|
V
|
F
|
T
|
V
|
230 |
K
|
E
|
A
|
A
|
A
|
Q
|
Q
|
Q
|
E
|
S
|
240 |
TM6 | |||||||||
A
|
T
|
T
|
Q
|
K
|
A
|
E
|
K
|
E
|
V
|
250 |
|
|||||||||
T
|
R
|
M
|
V
|
I
|
I
|
M
|
V
|
I
|
A
|
260 |
F
|
L
|
I
|
C
|
W
|
V
|
P
|
Y
|
A
|
S
|
270 |
V
|
A
|
F
|
Y
|
I
|
F
|
T
|
H
|
Q
|
G
|
280 |
|
|||||||||
ECL3 | TM7 | ||||||||
S
|
N
|
F
|
G
|
P
|
I
|
F
|
M
|
T
|
I
|
290 |
P
|
A
|
F
|
F
|
A
|
K
|
S
|
A
|
A
|
I
|
300 |
Y
|
N
|
P
|
V
|
I
|
Y
|
I
|
M
|
M
|
N
|
310 |
H8 | |||||||||
K
|
Q
|
F
|
R
|
N
|
C
|
M
|
L
|
T
|
T
|
320 |
C-term | |||||||||
I
|
C
|
C
|
G
|
K
|
N
|
P
|
L
|
G
|
D
|
330 |
D
|
E
|
A
|
S
|
A
|
T
|
V
|
S
|
K
|
T
|
340 |
E
|
T
|
S
|
Q
|
V
|
A
|
P
|
A
|
|
|
|
|
|
|
|
|
|
|
His(8) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MBP | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MBP | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PreScission | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T4 Lysozyme | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
N-term | |||||||||
M
|
C
|
G
|
T
|
E
|
G
|
P
|
N
|
F
|
Y
|
10 |
V
|
P
|
F
|
S
|
N
|
A
|
T
|
G
|
V
|
V
|
20 |
R
|
S
|
P
|
F
|
E
|
Y
|
P
|
Q
|
Y
|
Y
|
30 |
TM1 | |||||||||
L
|
A
|
E
|
P
|
W
|
Q
|
F
|
S
|
M
|
L
|
40 |
A
|
A
|
Y
|
M
|
F
|
L
|
L
|
I
|
V
|
L
|
50 |
G
|
F
|
P
|
I
|
N
|
F
|
L
|
T
|
L
|
Y
|
60 |
ICL1 | |||||||||
V
|
T
|
V
|
Q
|
H
|
K
|
K
|
L
|
R
|
T
|
70 |
TM2 | |||||||||
P
|
L
|
N
|
Y
|
I
|
L
|
L
|
N
|
L
|
A
|
80 |
V
|
A
|
D
|
L
|
F
|
M
|
V
|
L
|
G
|
G
|
90 |
F
|
T
|
S
|
T
|
L
|
Y
|
T
|
S
|
L
|
H
|
100 |
ECL1 | TM3 | ||||||||
G
|
Y
|
F
|
V
|
F
|
G
|
P
|
T
|
G
|
C
|
110 |
|
|||||||||
N
|
L
|
Q
|
G
|
F
|
F
|
A
|
T
|
L
|
G
|
120 |
G
|
E
|
I
|
A
|
L
|
W
|
S
|
L
|
V
|
V
|
130 |
L
|
A
|
I
|
E
|
R
|
Y
|
V
|
V
|
V
|
C
|
140 |
ICL2 | |||||||||
K
|
P
|
M
|
S
|
N
|
F
|
R
|
F
|
G
|
E
|
150 |
TM4 | |||||||||
N
|
H
|
A
|
I
|
M
|
G
|
V
|
A
|
F
|
T
|
160 |
W
|
V
|
M
|
A
|
L
|
A
|
C
|
A
|
A
|
P
|
170 |
ECL2 | |||||||||
P
|
L
|
A
|
G
|
W
|
S
|
R
|
Y
|
I
|
P
|
180 |
E
|
G
|
L
|
Q
|
C
|
S
|
C
|
G
|
I
|
D
|
190 |
Y
|
Y
|
T
|
L
|
K
|
P
|
E
|
V
|
N
|
N
|
200 |
TM5 | |||||||||
E
|
S
|
F
|
V
|
I
|
Y
|
M
|
F
|
V
|
V
|
210 |
H
|
F
|
T
|
I
|
P
|
M
|
I
|
I
|
I
|
F
|
220 |
F
|
C
|
Y
|
G
|
Q
|
L
|
V
|
F
|
T
|
V
|
230 |
K
|
E
|
A
|
A
|
A
|
Q
|
Q
|
Q
|
E
|
S
|
240 |
TM6 | |||||||||
A
|
T
|
T
|
Q
|
K
|
A
|
E
|
K
|
E
|
V
|
250 |
|
|||||||||
T
|
R
|
M
|
V
|
I
|
I
|
Y
|
V
|
I
|
A
|
260 |
F
|
L
|
I
|
C
|
W
|
V
|
P
|
Y
|
A
|
S
|
270 |
V
|
A
|
F
|
Y
|
I
|
F
|
T
|
H
|
Q
|
G
|
280 |
|
|||||||||
ECL3 | TM7 | ||||||||
S
|
C
|
F
|
G
|
P
|
I
|
F
|
M
|
T
|
I
|
290 |
P
|
A
|
F
|
F
|
A
|
K
|
S
|
A
|
A
|
I
|
300 |
Y
|
N
|
P
|
V
|
I
|
Y
|
I
|
M
|
M
|
N
|
310 |
H8 | |||||||||
K
|
Q
|
F
|
R
|
N
|
C
|
M
|
L
|
T
|
T
|
320 |
C-term | |||||||||
I
|
C
|
C
|
G
|
K
|
N
|
P
|
L
|
G
|
D
|
330 |
D
|
E
|
A
|
S
|
A
|
T
|
V
|
S
|
K
|
T
|
340 |
E
|
T
|
S
|
Q
|
V
|
A
|
P
|
A
|
348 |
|
|
|
|
|
|
|
|
|
|
|
AAAGSAGSAGS | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3A Arrestin | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
SCHEMATIC
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIAGRAMS
MUTATIONS
Position | Wild-type | Mutated |
---|---|---|
2 | | N | C |
113 | | E | Q |
257 | | M | Y |
282 | | N | C |
DELETIONS
MODIFICATIONS
AUXILIARY PROTEINS
Protein_type: tag
Name: His(8)
Sequence: None
Deletions:
Positions: N-term_0 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: fusion
Name: MBP
Sequence: None
Deletions:
Positions: N-term_1 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: fusion
Name: MBP
Sequence: None
Deletions:
Positions: N-term_2 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: prot_cleavage
Name: PreScission site (3C)
Sequence: None
Deletions:
Positions: N-term_3 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: fusion
Name: T4 Lysozyme (T4L)
Sequence: None
Deletions:
Positions: N-term_4 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: linker
Name: AAAGSAGSAGSAGSA
Sequence: None
Deletions:
Positions: C-term_5 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: fusion
Name: 3A Arrestin
Sequence: None
Deletions:
Positions: C-term_6 None:None
Presence in Crystal:YES
Remarks: None
EXPRESSION
Expression method | Host cell type | Host cell | Remarks |
---|---|---|---|
Transient_transfection | HEK293S | Mammalian | NOTE: tetracycline-inducible expression vector |
SOLUBILIZATION
Solvent type | Item | Concentration |
---|---|---|
additive | CHS | 0.1 %w/v |
detergent | DDM | 0.5 %w/v |
Remarks:
PURIFICATION
Purification type | Description |
---|---|
NONE | None |
Remarks:None
CRYSTALLIZATION
METHOD: in meso/LCP
TYPE: lipidic cubic phase (LCP) (monopalmitolein (9.7 MAG))
PROTEIN CONCENTRATION: 30 mg/ml
Temperature: 20°C
ph : 5.0-5.0
Remarks: Of all the lipids tested, only 9.7 MAG reproducibly facilitated the crystallization of the T4L-rhodopsin-arrestin complex, 9.7 MAG containing 10% (w/w) cholesterol at a 1:1 ratio … since 9.7 MAG had larger aqueous channels compared to 9.9 MAG
Chemical lists
Type | Item | Concentration |
---|---|---|
Additional | ||
unknown | PEG 400 | 28 % v/v |
unknown | Magnesium Acetate | 50 mM |
Buffer | ||
unknown | sodium acetate, pH 5.0 | 50 mM |
Detergent | ||
detergent | DDM | 0.5 %w/v |
Lipid | ||
lipid | CHS | 0.1 %w/v |